KBIO COMPANY Inc. Share Price

Equities

A038530

KR7038530002

Drug Retailers

End-of-day quote Korea S.E. 03:30:00 26/04/2024 am IST 5-day change 1st Jan Change
267 KRW -1.11% Intraday chart for KBIO COMPANY Inc. 0.00% -4.98%

Financials

Sales 2022 33.65B 24.46M 2.04B Sales 2023 27.32B 19.87M 1.66B Capitalization 32.45B 23.59M 1.97B
Net income 2022 -7.66B -5.57M -465M Net income 2023 -12.67B -9.21M -769M EV / Sales 2022 0.07 x
Net cash position 2022 34.57B 25.13M 2.1B Net cash position 2023 53.4B 38.82M 3.24B EV / Sales 2023 -0.77 x
P/E ratio 2022
-4.77 x
P/E ratio 2023
-2.26 x
Employees 36
Yield 2022 *
-
Yield 2023
-
Free-Float 66.73%
More Fundamentals * Assessed data
Dynamic Chart
Gold Pacific Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
INCON Co.,Ltd. announced that it has received KRW 10 billion in funding from Gold Pacific Co., Ltd. CI
Gold Pacific Co., Ltd. announced that it has received KRW 10.1 billion in funding CI
Gold Pacific Co., Ltd. announced that it expects to receive KRW 20 billion in funding from Ellim Corporation Co., Ltd. and other investors CI
Gold Pacific Co., Ltd. agreed to acquire Distribution Business of CureBio Co.,Ltd. for KRW 6.5 billion. CI
Gold Pacific Co., Ltd. announced that it has received KRW 8.001 billion in funding from Elim Corporation CI
Gold Pacific Co., Ltd. announced that it has received KRW 10 billion in funding CI
Gold Pacific Co., Ltd. announced that it expects to receive KRW 10 billion in funding CI
Arthur Mine Fund and Flare Fund acquired 9.6% stake in Jokwang ILI Co., Ltd. from Gold Pacific Co., Ltd. for KRW 9.7 billion. CI
Gold Pacific Co., Ltd. announced that it expects to receive KRW 10.000084 billion in funding from Elim Corporation CI
Gold Pacific Co., Ltd. announced that it has received KRW 10 billion in funding from Chorokbaem Media Co., Ltd., Philosys Healthcare Co., Ltd CI
Gold Pacific Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Chorokbaem Media Co., Ltd., Philosys Healthcare Co., Ltd CI
Gold Pacific Co., Ltd. cancelled the acquisition of an additional 16.4% stake in Incon Co., Ltd. from H.Anderson Co., Ltd. CI
Gold Pacific Co., Ltd. announced that it has received KRW 6 billion in funding CI
Gold Pacific Co., Ltd. announced that it expects to receive KRW 10 billion in funding CI
More news
1 day-1.11%
Current month-17.34%
1 month-16.04%
3 months+13.14%
6 months+6.80%
Current year-4.98%
More quotes
1 week
265.00
Extreme 265
286.00
1 month
260.00
Extreme 260
340.00
Current year
225.00
Extreme 225
376.00
1 year
225.00
Extreme 225
591.00
3 years
225.00
Extreme 225
2 585.00
5 years
225.00
Extreme 225
3 405.00
10 years
225.00
Extreme 225
21 800.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 01/20/01
Director of Finance/CFO 42 -
Director/Board Member 50 -
Members of the board TitleAgeSince
Chief Executive Officer 63 01/20/01
Director/Board Member 52 24/21/24
Director/Board Member 50 -
More insiders
Date Price Change Volume
29/24/29 289 +8.24% 6,598,562
26/24/26 267 -1.11% 360,162
25/24/25 270 -1.46% 283,384
24/24/24 274 -0.72% 301,269
23/24/23 276 +1.10% 278,667

End-of-day quote Korea S.E., April 26, 2024

More quotes
KBio Company Inc, formerly Gold Pacific Co Ltd, is a Korea-based company primarily engaged in the bio distribution business. The Company operates its business through three segments. The Bio Distribution segment is engaged in the supply of research reagents and consumables to each customer through hospitals, universities, research institutes, and dealers. The Fashion segment is engaged in the production and sale of products such as handmade leather goods, clothing, and accessories. The Other segment is engaged in the fashion promotion business and other businesses.
More about the company
  1. Stock Market
  2. Equities
  3. A038530 Stock